Top Markets
Coin of the day
Neurizon Therapeutics Limited Neurizon Therapeutics Limited

Neurizon Therapeutics Limited

NUZ
Ранг среди акций #27538
Neurizon Therapeutics Limited, a clinical stage biotechnology company, develops... Neurizon Therapeutics Limited, a clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases. The company develops drug discovery intellectual property for the treatment of neurological diseases. Its lead candidate is NUZ-001, a small molecule drug which is in Phase II clinical trials for the treatment of amyotrophic lateral sclerosis, as well as to treat other neurodegenerative diseases. The company was formerly known as PharmAust Limited and changed its name to Neurizon Therapeutics Limited in October 2024. Neurizon Therapeutics Limited was incorporated in 2000 and is based in Melbourne, Australia.
Цена акции
$0.0416118
Рыночная капитализация
$32.25M
Изменение (1 день)
-1.67%
Изменение (1 год)
-59.58%
Страна
AU
Торговля Neurizon Therapeutics Limited (NUZ)

Категория

Коэффициент P/B для Neurizon Therapeutics Limited (NUZ)
Коэффициент P/B на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций Neurizon Therapeutics Limited, текущий коэффициент P/B (TTM) составляет 0. В конце 2026 он составлял 0.
История P/B для Neurizon Therapeutics Limited с 2026 по 2026
Коэффициент P/B в конце каждого года
Год P/B Изменить
Недостаточно данных для указанных дат.
Коэффициент P/B для аналогичных компаний или конкурентов
Компания P/B Разница P/B Страна
6.3419 -
US
3.7087 -
US
6.2413 -
NL
2.5054 -
AU
- -
CH